3 Years After CRISPR Treatment 73 of 75 Patients Cured of Blood Disease – FDA Approval is Near

The first serious clinical trials in humans using CRISPR continue to wow, after follow-up findings three years post procedure demonstrate that all patients but two remain essentially cured of two blood disorders. The treatment involved taking samples of the patients’ stem cells, and using CRISPR Cas-9 gene editing to enhance the levels of fetal hemoglobin, […]

The post 3 Years After CRISPR Treatment 73 of 75 Patients Cured of Blood Disease – FDA Approval is Near appeared first on Good News Network.